Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 3031618)

Published in PLoS One on January 31, 2011

Authors

Lori D Hill1, Timothy P York, Juan P Kusanovic, Ricardo Gomez, Lindon J Eaves, Roberto Romero, Jerome F Strauss

Author Affiliations

1: Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States of America.

Articles citing this

Detecting epistasis in human complex traits. Nat Rev Genet (2014) 1.61

Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome. Mol Cell Endocrinol (2011) 1.38

Associations between maternal genotypes and metabolites implicated in congenital heart defects. Mol Genet Metab (2012) 0.92

Fetal and maternal genes' influence on gestational age in a quantitative genetic analysis of 244,000 Swedish births. Am J Epidemiol (2013) 0.91

DNA methylation is altered in maternal blood vessels of women with preeclampsia. Reprod Sci (2012) 0.87

Genetic variation throughout the folate metabolic pathway influences negative symptom severity in schizophrenia. Schizophr Bull (2011) 0.86

Malignant cancer and invasive placentation: A case for positive pleiotropy between endometrial and malignancy phenotypes. Evol Med Public Health (2014) 0.83

Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular disease. Arterioscler Thromb Vasc Biol (2014) 0.83

The contribution of genetic and environmental factors to the duration of pregnancy. Am J Obstet Gynecol (2013) 0.83

A Novel ERAP2 Haplotype Structure in a Chilean Population: Implications for ERAP2 Protein Expression and Preeclampsia Risk. Mol Genet Genomic Med (2013) 0.82

Metabolic pathways involved in 2-methoxyestradiol synthesis and their role in preeclampsia. Reprod Sci (2013) 0.81

Prolactin receptor gene polymorphisms are associated with gestational diabetes. Genet Test Mol Biomarkers (2013) 0.81

Levels of key enzymes of methionine-homocysteine metabolism in preeclampsia. Biomed Res Int (2013) 0.80

Protective Role of Maternal P.VAL158MET Catechol-O-Methyltransferase Polymorphism against Early-Onset Preeclampsia and its Complications. J Med Biochem (2016) 0.75

2-methoxyestradiol plasma levels are associated with clinical severity indices and biomarkers of preeclampsia. Reprod Sci (2014) 0.75

A Comparison of 2-Methoxyestradiol Value in Women with Severe Preeclampsia Versus Normotensive Pregnancy. J Clin Diagn Res (2017) 0.75

Articles cited by this

PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92

Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23

dbSNP: the NCBI database of genetic variation. Nucleic Acids Res (2001) 76.97

Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest (2003) 13.72

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol (2000) 11.11

Pre-eclampsia. Lancet (2005) 10.41

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A (2001) 9.42

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06

Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science (2006) 6.71

Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med (2006) 6.21

Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet (2004) 5.87

Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol (1989) 5.73

Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev (1998) 4.29

Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev (1999) 3.81

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med (2008) 3.39

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet (2002) 3.38

Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol (1996) 3.34

Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry (2003) 3.12

Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol Psychiatry (2005) 2.36

Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review. Placenta (2003) 2.31

Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry (1999) 2.11

Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature (2008) 2.09

Placental stress and pre-eclampsia: a revised view. Placenta (2009) 2.08

Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest (1993) 2.07

[A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000]. Rev Med Chil (2004) 1.94

Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens (1991) 1.86

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med (2009) 1.84

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol (2004) 1.81

The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol (1967) 1.79

Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol (2005) 1.60

Is the common 677C-->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJM (1997) 1.59

Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet (1998) 1.53

Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences. Am J Pharmacogenomics (2001) 1.46

The familial factor in toxemia of pregnancy. Obstet Gynecol (1968) 1.44

Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes. Hum Hered (2006) 1.41

Searching for genetic clues to the causes of pre-eclampsia. Clin Sci (Lond) (2006) 1.33

Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Am J Med Genet (2000) 1.32

MTHFR 677C --> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val --> Met. Proc Natl Acad Sci U S A (2008) 1.30

Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies--a review. Placenta (2002) 1.26

Homocysteine: overview of biochemistry, molecular biology, and role in disease processes. Semin Vasc Med (2005) 1.25

Prenatal medicine: the child is the father of the man. 1996. J Matern Fetal Neonatal Med (2009) 1.24

Phenotypic and metabolic characteristics of monocytes and granulocytes in preeclampsia. Am J Obstet Gynecol (2001) 1.23

Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet (2007) 1.21

The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels. Arch Med Res (2007) 1.21

Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab (1998) 1.17

Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab (2007) 1.14

2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis. Am J Pathol (2008) 1.14

Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction. Am J Obstet Gynecol (2006) 1.09

Pre-eclampsia and maternal anaemia display reduced apoptosis and opposite invasive phenotypes of extravillous trophoblast. Placenta (2003) 1.09

A STUDY OF THE SPIRAL ARTERIES OF THE DECIDUA BASALIS IN NORMOTENSIVE AND HYPERTENSIVE PREGNANCIES. J Obstet Gynaecol Br Commonw (1964) 1.06

Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions. Am J Pathol (2010) 1.03

No evidence for an effect of COMT Val158Met genotype on executive function in patients with 22q11 deletion syndrome. Am J Psychiatry (2006) 1.02

Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men. Metabolism (2008) 0.98

Association between catechol O-methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in adults. Am J Med Genet B Neuropsychiatr Genet (2009) 0.98

The great obstetrical syndromes. J Matern Fetal Neonatal Med (2009) 0.98

Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens (2004) 0.96

Catechol-o-methyl transferase activity in the human term placenta. Am J Perinatol (1988) 0.93

The 108M polymorph of human catechol O-methyltransferase is prone to deformation at physiological temperatures. Biochemistry (2006) 0.93

The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications. Pharmacogenet Genomics (2008) 0.92

Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome. Reprod Sci (2008) 0.91

The effect of CYP19 and COMT polymorphisms on exercise-induced fat loss in postmenopausal women. Obes Res (2004) 0.91

Differences in methylenetetrahydrofolate reductase genotype frequencies, between Whites and Blacks. Am J Hum Genet (1997) 0.91

Functional maternal catechol-O-methyltransferase polymorphism and fetal growth restriction. Pharmacogenet Genomics (2006) 0.90

Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo women. Hypertens Res (2008) 0.90

Analytical approaches to detect maternal/fetal genotype incompatibilities that increase risk of pre-eclampsia. BMC Med Genet (2008) 0.89

Catechol-O-methyltransferase and Parkinson's disease. Acta Med Okayama (2002) 0.85

Endothelial cell activation as a pathogenetic factor in preeclampsia. Semin Perinatol (1991) 0.81

Genetic modeling of estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas (2002) 0.81

Hyperhomocysteinaemia: a risk factor for preeclampsia? Eur J Obstet Gynecol Reprod Biol (2001) 0.80

Articles by these authors

Epidemiology and causes of preterm birth. Lancet (2008) 18.96

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06

A systems biology approach for pathway level analysis. Genome Res (2007) 6.95

Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med (2006) 6.21

A novel signaling pathway impact analysis. Bioinformatics (2008) 5.06

Derivation of oocytes from mouse embryonic stem cells. Science (2003) 4.03

Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care (2004) 3.59

Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med (2012) 3.43

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med (2008) 3.39

Inflammation and pregnancy. Reprod Sci (2009) 3.33

Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One (2008) 3.01

A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol Med (2004) 2.98

Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet (2008) 2.90

Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch Gen Psychiatry (2004) 2.84

Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol (2007) 2.78

The role of the children of twins design in elucidating causal relations between parent characteristics and child outcomes. J Child Psychol Psychiatry (2003) 2.61

A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol (2004) 2.60

Machine learning and its applications to biology. PLoS Comput Biol (2007) 2.57

Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol (2003) 2.55

High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications (2002) 2.42

Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev (2002) 2.42

The fetal inflammatory response syndrome. Clin Obstet Gynecol (2007) 2.36

Listeriosis in human pregnancy: a systematic review. J Perinat Med (2011) 2.20

The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified? Am J Obstet Gynecol (2006) 2.11

Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature (2008) 2.09

The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. Am J Obstet Gynecol (2010) 1.99

Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med (2005) 1.99

Evolution of the mammalian placenta revealed by phylogenetic analysis. Proc Natl Acad Sci U S A (2006) 1.89

Genomics, biogeography, and the diversification of placental mammals. Proc Natl Acad Sci U S A (2007) 1.86

Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab (2010) 1.84

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med (2009) 1.84

A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med (2006) 1.82

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol (2004) 1.81

Evaluation of analyses of univariate discrete twin data. Behav Genet (2002) 1.78

Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. J Matern Fetal Neonatal Med (2010) 1.77

Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol (2010) 1.77

Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis. Am J Obstet Gynecol (2009) 1.77

Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril (2006) 1.75

Identification of fetal and maternal single nucleotide polymorphisms in candidate genes that predispose to spontaneous preterm labor with intact membranes. Am J Obstet Gynecol (2010) 1.75

Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol (2010) 1.74

Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature. Am J Obstet Gynecol (2006) 1.73

Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 1.69

Gene-centric genomewide association study via entropy. Genetics (2008) 1.68

Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ (2011) 1.67

Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol (2011) 1.65

Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol (2004) 1.64

A short cervix in women with preterm labor and intact membranes: a risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol (2005) 1.64

Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. J Matern Fetal Neonatal Med (2007) 1.62

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med (2008) 1.60

Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol (2004) 1.60

The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem (2003) 1.59

Intrauterine endotoxin administration leads to white matter diffusivity changes in newborn rabbits. J Child Neurol (2009) 1.58

Health disparities in risk for cervical insufficiency. Hum Reprod (2010) 1.58

Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol (2002) 1.58

Structural and functional comparison of mast cells in the pregnant versus nonpregnant human uterus. Am J Obstet Gynecol (2006) 1.54

The clinical significance of a positive Amnisure test in women with term labor with intact membranes. J Matern Fetal Neonatal Med (2009) 1.54

A systematic approach to the use of the multiplanar display in evaluation of abnormal vascular connections to the fetal heart using 4-dimensional ultrasonography. J Ultrasound Med (2007) 1.53

Analysis of microarray experiments of gene expression profiling. Am J Obstet Gynecol (2006) 1.53

Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol (2004) 1.51

Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab (2006) 1.51

Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet (2011) 1.51

Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol (2009) 1.50

The evolution of menstruation: a new model for genetic assimilation: explaining molecular origins of maternal responses to fetal invasiveness. Bioessays (2011) 1.50

The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med (2008) 1.50

Toll-like receptor-2 and -4 in the chorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioamnionitis. Am J Obstet Gynecol (2004) 1.49

The prognosis of pregnancy conceived despite the presence of an intrauterine device (IUD). J Perinat Med (2010) 1.48

Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol (2007) 1.47

The risk of impending preterm delivery in asymptomatic patients with a nonmeasurable cervical length in the second trimester. Am J Obstet Gynecol (2010) 1.45

Analysis and interpretation of twin studies including measures of the shared environment. Child Dev (2005) 1.43

Genes determine stability and the environment determines change in cognitive ability during 35 years of adulthood. Psychol Sci (2009) 1.42

A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem (2001) 1.42

NIH funding reform. Science (2005) 1.41

A comparison of gene set analysis methods in terms of sensitivity, prioritization and specificity. PLoS One (2013) 1.41

Candidate-gene association study of mothers with pre-eclampsia, and their infants, analyzing 775 SNPs in 190 genes. Hum Hered (2006) 1.41

Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature Challenge. Bioinformatics (2013) 1.39

Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol (2010) 1.39

Genetic and environmental influences on the transmission of parental depression to children's depression and conduct disturbance: an extended Children of Twins study. J Child Psychol Psychiatry (2010) 1.39

Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome. Mol Cell Endocrinol (2011) 1.38

The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol (2003) 1.38

TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes. J Immunol (2009) 1.37

Genetic contributions to disparities in preterm birth. Pediatr Res (2009) 1.37

The transcriptome of the fetal inflammatory response syndrome. Am J Reprod Immunol (2010) 1.37

Molecular progress in infertility: polycystic ovary syndrome. Fertil Steril (2002) 1.36

Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy. Am J Obstet Gynecol (2008) 1.36

Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum Mol Genet (2004) 1.35